Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calcium-activated chloride channel regulator 1 (CLCA1) is a secreted protein involved in the regulation of calcium-dependent chloride channels (CaCCs). It modulates TMEM16A/ANO1 channels on cell surfaces, affecting electrolyte and fluid secretion, mucus production, and cellular signaling. CLCA1 contains a von Willebrand factor type A (VWA) domain and a zinc metalloprotease domain. It undergoes self-cleavage in the endoplasmic reticulum to produce an N-terminal fragment that is essential for activating CaCCs.
Paracrine activation; secreted soluble CLCA1 interacts with neighboring cell membranes where TMEM16A resides; cleaved N-terminal VWA domain binds TMEM16A directly to potentiate Ca2+-dependent Cl− conductance
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calcium-activated chloride channel protein regulator 1.